Endothelial dysfunction in adiponectin deficiency and its mechanisms involved

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Vascular Medicine

Background:

• Endothelial dysfunction is a key factor in diabetic vascular disease and atherosclerosis.
• Reduced plasma adiponectin (APN) levels in diabetics suggest a link to endothelial dysfunction, but mechanisms are unclear.

Purpose of the Study:

• To investigate if adiponectin (APN) deficiency causes endothelial dysfunction.
• To elucidate the underlying mechanisms of APN deficiency-induced endothelial dysfunction.

Main Methods:

• Comparison of vascular function in wild-type (WT) and adiponectin knockout (APN(-/-)) mouse aortic rings.
• Assessment of vasorelaxation, nitric oxide (NO) production, eNOS activity, and oxidative stress markers.
• In vivo administration of adiponectin globular domain to APN(-/-) mice.

Main Results:

• APN(-/-) mice exhibited impaired vasorelaxation to acetylcholine (endothelial-dependent) but not to acidified NaNO2 (endothelial-independent).
• APN deficiency led to increased superoxide and peroxynitrite production, with reduced NO production and eNOS phosphorylation.
• In vivo treatment with adiponectin globular domain improved endothelial function and reduced oxidative stress in APN(-/-) mice.

Conclusions:

• Adiponectin deficiency contributes to endothelial dysfunction through increased oxidative stress and reduced nitric oxide bioavailability.
• Therapeutic strategies aimed at increasing adiponectin levels may ameliorate endothelial dysfunction and reduce cardiovascular risk in diabetic patients.